This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
06/02/15 - 11:40:25 AM ET (BATS BZX Real-time Price)
Div Yield: --
XLRN Day's Range
XLRN 52 Week Range
XLRN Business Summary
Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases.View XLRN key stats
Acceleron Pharma Inc - XLRN - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Acceleron Pharma Inc as a
Sell with a ratings score of D.
Report Snippet: We rate ACCELERON PHARMA INC (XLRN) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow and feeble growth in its earnings per share.